Skip to main content
Clinical Trials/NCT02812446
NCT02812446CompletedNot Applicable

Staphylokinase and ABO Group Phenotype: New Players in Staphylococcus Aureus Implant-associated Infections Development

Nantes University Hospital1 site in 1 country88 target enrollmentStarted: February 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
88
Locations
1
Primary Endpoint
IAI and NC nasal carriage isolates genetic background

Study Overview

Brief Summary

The purpose of this study is to identify bacterial and/or clinical features involved in the pathogenesis of Staphylococcus aureus implant-associated infections (IAI). Materials & methods: In total, 57 IAI S. aureus and 31 nasal carriage (NC) S. aureus isolates were studied. Staphylococcus aureus genetic background was obtained by microarray analysis. Multilocus sequence typing was performed to determine clonal complexes (CC). Biofilm production was investigated by resazurin and crystal violet methods

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •infected patients with S. Aureus IAI infection
  • •noninfected patients screened for S. aureus nasal colonization at the orthopedic consultation ward

Exclusion Criteria

  • Not provided

Arms & Interventions

control group

patients with Staphylococcus aureus nasal carriage

Intervention: Staphylococcus aureus nasal carriage infection (Other)

IAI patients group

patients with Staphylococcus aureus of implant-associated infections

Intervention: IAI infection (Other)

Outcomes

Primary Outcomes

IAI and NC nasal carriage isolates genetic background

Time Frame: september 2012

IAI and NC isolates genetic background was determined in order to compare the prevalence of individual virulence factor genes. All genes provided by the Alere StaphyType DNA microarray were studied

biofilm production measurement in the two groups

Time Frame: september 2012

The primary aim of this study is to identify phenotypic (biofilm production) markers in two different groups of S. aureus strains isolated from patients with IAI or screened from nasal carrier in noninfected patients undergoing orthopedic surgery. By using resazurin method, IAI and NC nasal carriage isolates were divided into three groups. Isolates were classified as strong, moderate and weak biofilm producers.

Clonal complexes distribution

Time Frame: september 2012

The primary aim of this study is to identify genotypic markers in two different groups of S. aureus strains isolated from patients with IAI or screened from nasal carrier in noninfected patients undergoing orthopedic surgery. IAI and NC isolates genetic background was determined in order to compare the prevalence of individual virulence factor genes. All genes provided by the Alere StaphyType DNA microarray were studied.

Secondary Outcomes

  • biofilm production correlation with genotype(december 2013)
  • Association of ABO group phenotype and IAI S. aureus genotype(december 2013)
  • Correlation between Clonal Complexes distribution , genotype and clinical parameters(december 2013)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials